Over the past year, the world has become intimately familiar with the term “Supply Chain” and the many challenges associated with regular supply during times of disruption. Across industries, global supply networks are being stretched and tested, and even the most resilient enterprises are facing challenges to navigate the pandemic.
Today, no industry has as much focus on Supply Chain resiliency as Biopharma. World leaders are commenting on the capabilities to rapidly supply millions of doses of therapeutics and vaccines. Therefore, “Supply Chain” has become a hot topic for media outlets around the globe.
Given the Life Science industry’s direct impact on pandemics, perhaps no industry has done as much preparation for such an event. Even still, the magnitude and speed of Covid-19 has challenged even the best equipped organizations.
In this webinar, we will discuss the preparations that were in place before Covid-19. For example, what pandemic planning was in place before Covid-19? What challenges did we face in preparing for a pandemic? We will cover the adjustments and challenges that arose during the pandemic. What surprised us? Where were the weak points in our Supply Chain? Where did we find success?
And finally, we will cover the lessons learned for how MilliporeSigma/Merck KGaA will be better prepared in the future.
Areas of strength from our preparations
Weak points in the Supply Chain
Adjustments and actions through the Supply Chain
We look forward to seeing you online!